AR005986A1 - Derivados de 2-thioxo-tetrahidropirimidin-4-ona, el uso de los mismos para preparar un medicamento y una composicion farmaceutica que los contiene - Google Patents
Derivados de 2-thioxo-tetrahidropirimidin-4-ona, el uso de los mismos para preparar un medicamento y una composicion farmaceutica que los contieneInfo
- Publication number
- AR005986A1 AR005986A1 ARP970100745A ARP970100745A AR005986A1 AR 005986 A1 AR005986 A1 AR 005986A1 AR P970100745 A ARP970100745 A AR P970100745A AR P970100745 A ARP970100745 A AR P970100745A AR 005986 A1 AR005986 A1 AR 005986A1
- Authority
- AR
- Argentina
- Prior art keywords
- derivatives
- prepare
- pharmaceutical composition
- tetrahidropirimidin
- thioxo
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- JWTRBTSBTPEKHZ-UHFFFAOYSA-N 2-sulfanyl-2,3-dihydro-1H-pyrimidin-4-one Chemical class OC1=NC(S)=NCC1 JWTRBTSBTPEKHZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 208000032928 Dyslipidaemia Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000003143 atherosclerotic effect Effects 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se refiere a derivados de 2-tioxotetrahidropirimidin-4-ona para aumentar la concentración de colesterol de HDL, al uso de los mismos para prepararun medicamento y a una composición farmacéutica para tratar estados ateroescleróticos, tales como enfermedad cardíaca coronaria ydislipoproteinemias. Los compuestos están representados por la fórmula (I), donde R es alquilo C1-C6, alquenilo C2-C6; y R1, R2 y R3 sonindependientemente hidrógeno, halógeno o un alquilo inferior.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1299396P | 1996-03-07 | 1996-03-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR005986A1 true AR005986A1 (es) | 1999-07-21 |
Family
ID=21757747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970100745A AR005986A1 (es) | 1996-03-07 | 1997-02-24 | Derivados de 2-thioxo-tetrahidropirimidin-4-ona, el uso de los mismos para preparar un medicamento y una composicion farmaceutica que los contiene |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5807864A (es) |
| EP (1) | EP0885197A1 (es) |
| JP (1) | JP2000507926A (es) |
| KR (1) | KR19990087582A (es) |
| CN (1) | CN1217715A (es) |
| AR (1) | AR005986A1 (es) |
| AU (1) | AU707732B2 (es) |
| BR (1) | BR9708310A (es) |
| CA (1) | CA2247933A1 (es) |
| HU (1) | HUP9901968A3 (es) |
| IL (1) | IL125974A0 (es) |
| NZ (1) | NZ332199A (es) |
| TW (1) | TW422840B (es) |
| WO (1) | WO1997032855A1 (es) |
| ZA (1) | ZA971911B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998021190A1 (en) * | 1996-11-14 | 1998-05-22 | American Home Products Corporation | Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents |
| US6562814B2 (en) | 2000-10-02 | 2003-05-13 | Wyeth | 3-thioxo-[1,2,4]-oxadiazinan-5-one derivatives |
| US20050096319A1 (en) * | 2003-02-21 | 2005-05-05 | Balzarini Jan M.R. | Identification of compounds that inhibit replication of human immunodeficiency virus |
| CN102423314A (zh) * | 2011-11-26 | 2012-04-25 | 济南环肽医药科技有限公司 | 一种治疗免疫性肝损伤或免疫性肝纤维化的药物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55108858A (en) * | 1979-02-14 | 1980-08-21 | Kyowa Hakko Kogyo Co Ltd | Novel dihydrouracil derivative and herbicide |
| JPS5939875A (ja) * | 1982-08-31 | 1984-03-05 | Sagami Chem Res Center | ５−トリフルオロメチルジヒドロウラシル類の製造方法 |
| JPS60243017A (ja) * | 1984-05-16 | 1985-12-03 | Kyowa Hakko Kogyo Co Ltd | 抗けいれん組成物 |
| JPH0651682B2 (ja) * | 1986-09-05 | 1994-07-06 | 株式会社上野製薬応用研究所 | ウラシル誘導体の製造方法 |
| US4927451A (en) * | 1988-12-30 | 1990-05-22 | Uniroyal Chemical Company, Inc. | 3-aryldihydrouracils |
| DE4318550A1 (de) * | 1993-06-04 | 1994-12-08 | Boehringer Mannheim Gmbh | Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US5554607A (en) * | 1995-11-28 | 1996-09-10 | American Home Products Corporation | Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis |
-
1997
- 1997-02-12 EP EP97906583A patent/EP0885197A1/en not_active Withdrawn
- 1997-02-12 JP JP9531771A patent/JP2000507926A/ja active Pending
- 1997-02-12 HU HU9901968A patent/HUP9901968A3/hu unknown
- 1997-02-12 KR KR1019980707023A patent/KR19990087582A/ko not_active Withdrawn
- 1997-02-12 IL IL12597497A patent/IL125974A0/xx unknown
- 1997-02-12 WO PCT/US1997/002281 patent/WO1997032855A1/en not_active Ceased
- 1997-02-12 NZ NZ332199A patent/NZ332199A/en unknown
- 1997-02-12 CA CA002247933A patent/CA2247933A1/en not_active Abandoned
- 1997-02-12 CN CN97194335A patent/CN1217715A/zh active Pending
- 1997-02-12 BR BR9708310A patent/BR9708310A/pt not_active Application Discontinuation
- 1997-02-12 AU AU21237/97A patent/AU707732B2/en not_active Ceased
- 1997-02-20 TW TW086102010A patent/TW422840B/zh active
- 1997-02-24 AR ARP970100745A patent/AR005986A1/es unknown
- 1997-02-27 US US08/807,164 patent/US5807864A/en not_active Expired - Lifetime
- 1997-03-05 ZA ZA971911A patent/ZA971911B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ332199A (en) | 1999-03-29 |
| JP2000507926A (ja) | 2000-06-27 |
| TW422840B (en) | 2001-02-21 |
| AU2123797A (en) | 1997-09-22 |
| US5807864A (en) | 1998-09-15 |
| WO1997032855A1 (en) | 1997-09-12 |
| CA2247933A1 (en) | 1997-09-12 |
| AU707732B2 (en) | 1999-07-15 |
| HUP9901968A3 (en) | 2000-01-28 |
| IL125974A0 (en) | 1999-04-11 |
| ZA971911B (en) | 1998-09-07 |
| CN1217715A (zh) | 1999-05-26 |
| HUP9901968A2 (hu) | 1999-10-28 |
| BR9708310A (pt) | 1999-08-03 |
| KR19990087582A (ko) | 1999-12-27 |
| EP0885197A1 (en) | 1998-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9808953A (pt) | Composto, processo para tratar um distúrbio mediado pela ciclooxigenase-2 em um paciente, e, composição farmacêutica | |
| AR034858A1 (es) | Compuestos elevadores de abca-1,composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento | |
| BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| AR032471A1 (es) | Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter | |
| MX9704777A (es) | Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen. | |
| CO4810373A1 (es) | Compuestos azapoliciclicos condensados con arilo | |
| BR9916282A (pt) | Composto, uso de um um composto e método de tratamento | |
| AR001332A1 (es) | Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen. | |
| ATE219363T1 (de) | Lösliche prodrugs von paclitaxel | |
| ATE249213T1 (de) | Pentafluorobenzensulfonamiden und analoge | |
| MX9300786A (es) | Compuestos hipolipidaemicos. | |
| BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
| ES2114931T3 (es) | Nuevos esteres esteroidales. | |
| ES2183180T3 (es) | Nuevos derivados de guanidina, procedimientos para su preparacion y su uso como medicamento. | |
| AR034120A1 (es) | Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico | |
| AR006401A1 (es) | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. | |
| BR0012610A (pt) | Novo derivado de difenilpiperidina | |
| GT199900081A (es) | Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos. | |
| PA8542601A1 (es) | Bifenilcarboxamidas reductoras de lipidos | |
| FI803264L (fi) | 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel | |
| PA8534001A1 (es) | Derivados de piperazina 1,4-disustituida utiles como bloqueadores alfa1,-adrenoceptores uro-selectivos | |
| BRPI9509819B8 (pt) | benzamida enterocinética e composição farmacêutica compreendendo a mesma | |
| ES2109229T3 (es) | Sulfonamidas sustituidas y compuestos relacionados para el tratamiento del asma, la artritis y enfermedades relacionadas. | |
| AR018347A1 (es) | 1h-indazoles 1,5 y 3-o-sustituidos y sus sales fisiologicamente tolerables, utilizacion de los mismos para la preparacion de medicamentos, procedimientospara preparar dichos compuestos, las composiciones y preparaciones farmaceuticas que los contienen, y la utilizacion de dichos compuestos y prepara | |
| BR0309668A (pt) | Imidazolinilmetil aralquilsulfonamidas |